These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12973010)

  • 1. Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma.
    Kim CE; Joyce JM; Patel N; Lichter J
    Clin Nucl Med; 2003 Sep; 28(9):782-3. PubMed ID: 12973010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
    Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
    Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.
    Mehta A; Muthukrishnan A
    Hell J Nucl Med; 2011; 14(2):186-7. PubMed ID: 21761029
    [No Abstract]   [Full Text] [Related]  

  • 4. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.
    Are C; Hsu JF; Ghossein RA; Schoder H; Shah JP; Shaha AR
    Ann Surg Oncol; 2007 Nov; 14(11):3210-5. PubMed ID: 17713821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of BRAF mutation and SUV
    Ozderya A; Temizkan S; Gul AE; Ozugur S; Sargin M; Aydin K
    Endocrine; 2017 Jan; 55(1):215-222. PubMed ID: 27696232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer.
    Guidoccio F; Grosso M; Antonelli A
    Endocrine; 2015 Sep; 50(1):260-1. PubMed ID: 25480655
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
    Leboeuf R; Bénard F; Langlois MF
    Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Papillary thyroid carcinoma synchronous with breast cancer: an incidental finding in an (18)F-FDG PET-CT study carried out in a search for occult breast cancer].
    Banzo J; Ubieto MA; González C; Razola P; Tardín L; Andrés A; Santapau A; Parra A; Rambalde EF; Prats E
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):213-5. PubMed ID: 23067689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary diagnosis of papillary thyroid carcinoma in the framework of staging of malignant melanoma with F-18 deoxyglucose using PET].
    Menzel C; Risse JH; Biersack HJ; Grünwald F
    Nuklearmedizin; 2001 Jun; 40(3):N23-4. PubMed ID: 11475082
    [No Abstract]   [Full Text] [Related]  

  • 10. Two Cases of Synchronous Hodgkin Lymphoma and Papillary Thyroid Carcinoma in 18 F-FDG PET/CT.
    Wang R; Cai H; Liu C; Lv Z; Ma C
    Clin Nucl Med; 2024 Jul; 49(7):650-651. PubMed ID: 38689445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
    Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
    Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
    Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
    J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
    Van den Bruel A; Maes A; De Potter T; Mortelmans L; Drijkoningen M; Van Damme B; Delaere P; Bouillon R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1517-20. PubMed ID: 11932274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
    Hooft L; Hoekstra OS; Devillé W; Lips P; Teule GJ; Boers M; van Tulder MW
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3779-86. PubMed ID: 11502811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
    Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
    Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.